Skip to main content

Animations

MJFF Publications

3651 - 3660 of 9145 Results
Title
Year
  • Year
  • 2020
  • 2024
  • 2024
  • 2023
  • 2020
  • 2020
  • 2019
  • 2020
  • 2020
  • 2020
  • Summary Details
    OPEN
    Title: Transcriptomic signatures of brain regional vulnerability to Parkinson’s disease
    Journal Name: Communications Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s42003-020-0804-9
    Citation Count: 85
  • Summary Details
    OPEN
    Title: Longitudinal brain structure changes in Parkinson’s disease: A replication study
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0295069
    Citation Count: 9
  • Summary Details
    OPEN
    Title: GABAergic regulation of striatal spiny projection neurons depends upon their activity state
    Journal Name: PLOS Biology
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pbio.3002483
    Citation Count: 28
  • Summary Details
    OPEN
    Title: Cell-type-directed design of synthetic enhancers
    Journal Name: Nature
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41586-023-06936-2
    Citation Count: 156
  • Discriminating α-synuclein strains in Parkinson’s disease and multiple system atrophy
    2020
    Summary Details
    RESTRICTED
    Title: Discriminating α-synuclein strains in Parkinson’s disease and multiple system atrophy
    Journal Name: Nature
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s41586-020-1984-7
    Citation Count: 856
  • Summary Details
    OPEN
    Title: Highly-selective µ-opioid receptor antagonism does not block L-DOPA-induced dyskinesia in a rodent model
    Journal Name: BMC Research Notes
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13104-020-04994-7
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Apathy rating scores and β-amyloidopathy in patients with Parkinson disease at risk for cognitive decline
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000008683
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Brain Damage With Heart Failure
    Journal Name: Circulation Research
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1161/circresaha.119.315813
    Citation Count: 93
  • Summary Details
    OPEN
    Title: A peripheral neutrophil-related inflammatory factor predicts a decline in executive function in mild Alzheimer’s disease
    Journal Name: Journal of Neuroinflammation
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12974-020-01750-3
    Citation Count: 67
  • Summary Details
    OPEN
    Title: Microglia clear neuron-released α-synuclein via selective autophagy and prevent neurodegeneration
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-020-15119-w
    Citation Count: 534
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.